scholarly article | Q13442814 |
P356 | DOI | 10.1111/J.1537-2995.2005.00559.X |
P698 | PubMed publication ID | 16131380 |
P50 | author | Agnieszka Orzińska | Q59164058 |
Katarzyna Guz | Q59164059 | ||
Ewa Brojer | Q59164060 | ||
P2093 | author name string | Zupanska B | |
Kaliñska A | |||
P2860 | cites work | RHD positive haplotypes in D negative Europeans | Q24801894 |
Prenatal Diagnosis of Fetal RhD Status by Molecular Analysis of Maternal Plasma | Q28314918 | ||
A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma | Q33361680 | ||
Molecular biology and genetics of the Rh blood group system | Q33904193 | ||
Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. | Q34385131 | ||
Prenatal typing of Rh and Kell blood group system antigens: the edge of a watershed | Q35043252 | ||
Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service | Q40626763 | ||
Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhD-negative pregnant women. | Q50792929 | ||
Prenatal genotyping of RHD and SRY using maternal blood. | Q54741354 | ||
Presence of fetal DNA in maternal plasma and serum | Q57075132 | ||
Specificity and sensitivity of RHD genotyping methods by PCR-based DNA amplification | Q57208567 | ||
P433 | issue | 9 | |
P304 | page(s) | 1473-1480 | |
P577 | publication date | 2005-09-01 | |
P1433 | published in | Transfusion | Q15758500 |
P1476 | title | Noninvasive determination of fetal RHD status by examination of cell-free DNA in maternal plasma | |
P478 | volume | 45 |
Q36423067 | 14 Years of Polish Experience in Non-Invasive Prenatal Blood Group Diagnosis |
Q35111355 | Direct quantification of cell-free, circulating DNA from unpurified plasma |
Q45984957 | Evaluation of single-nucleotide polymorphisms as internal controls in prenatal diagnosis of fetal blood groups. |
Q36654711 | Fetal DNA in maternal plasma: progress through epigenetics |
Q36837125 | Fetal RHD Genotyping Using Real-Time Polymerase Chain Reaction Analysis of Cell-Free Fetal DNA in Pregnancy of RhD Negative Women in South of Iran. |
Q33917070 | Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women |
Q83711565 | Fetal RHD genotyping by analysis of maternal plasma in a mixed population |
Q54393922 | Fetal RHD genotyping in maternal plasma at 11-13 weeks of gestation. |
Q38178923 | Integration of noninvasive prenatal prediction of fetal blood group into clinical prenatal care |
Q33263722 | MALDI-TOF mass spectrometry for quantitative, specific, and sensitive analysis of DNA and RNA. |
Q34399889 | Non-invasive prenatal diagnostic test accuracy for fetal sex using cell-free DNA a review and meta-analysis |
Q35040804 | Non-invasive prenatal testing of trisomy 18 by an epigenetic marker in first trimester maternal plasma |
Q87466211 | Noninvasive fetal RhD genotyping |
Q54433693 | Noninvasive fetal RhD genotyping from maternal blood. |
Q34192088 | Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience |
Q37322448 | Prenatal diagnosis: update on invasive versus noninvasive fetal diagnostic testing from maternal blood |
Q33873433 | RHD variants in Polish blood donors routinely typed as D- |
Q37000825 | Recent advances in non-invasive prenatal DNA diagnosis through analysis of maternal blood. |
Q35742103 | Risky Bodies in the Plasma Bioeconomy: A Feminist Analysis |
Q36423155 | The Glass Slide Extraction System Snap Card Improves Non-Invasive Prenatal Genotyping in Pregnancies with Antibodies |
Q26995586 | Tracking fetal development through molecular analysis of maternal biofluids |
Q54159132 | Unmethylated-maspin DNA in maternal plasma is associated with severe preeclampsia. |
Search more.